𝔖 Bobbio Scriptorium
✦   LIBER   ✦

1–33 Predicting Tissue HER2 Status Using Serum HER2 Levels in Patients with Metastatic Breast Cancer

✍ Scribed by Gilcrease, M.Z.

Book ID
123360830
Publisher
Elsevier Science
Year
2007
Tongue
English
Weight
120 KB
Volume
18
Category
Article
ISSN
1043-321X

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Serum epidermal growth factor receptor/H
Serum epidermal growth factor receptor/HER-2 predicts poor survival in patients with metastatic breast cancer
✍ Christopher Souder; Kim Leitzel; Suhail M. Ali; Laurence Demers; Dean B. Evans; 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 205 KB 👁 2 views

## Abstract ## BACKGROUND. Epidermal growth factor receptor (EGFR, HER‐1, and __erbB__1) is overexpressed in primary breast cancer and had been identified as a poor prognostic factor. ## METHODS. Pretreatment serum EGFR levels were quantified by using an enzyme‐linked immunoadsorbent assay in a